Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Schwab US Large Cap Growth ETF — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while Schwab US Large Cap Growth ETF trades at $35.57 (market cap $65.41B). The key difference: Schwab US Large Cap Growth ETF is far larger — about 9.2× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Schwab US Large Cap Growth ETF for 52 Days on average.
| IONS | SCHG | |
|---|---|---|
Market Cap | $7.10B | $65.41B |
Volume | 2,027,457 | 7,603,969 |
Sector | Health | Sector/Thematic |
52-Week High | $86.50 | $36.93 |
52-Week Low | $42.38 | $28.10 |
Typical Hold Time | 0 Days | 52 Days |
Enterprise Value | $6.66B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHG, the Schwab U.S. Large-Cap Growth ETF, trades at $36.59 with a bullish technical signal supported by moving averages. The ETF maintains neutral momentum oscillators with RSI levels around 60. Recent news highlights SCHG's position as a low-cost growth ETF option with strong historical performance, though some analysts note concentration risks in top holdings.
SCHG offers exposure to large-cap growth stocks with competitive expense ratios, but faces competition from similar ETFs. Key risks include concentration in megacap technology stocks and market volatility. The ETF remains a core growth allocation for investors seeking diversified large-cap exposure with low fees.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
